Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 141* | 2020 |
Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features A Lanzós, J Carlevaro-Fita, L Mularoni, F Reverter, E Palumbo, R Guigó, ... Scientific Reports. 2017; 7: 41544, 2017 | 62 | 2017 |
Hacking the cancer genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening R Esposito, N Bosch, A Lanzós, T Polidori, C Pulido-Quetglas, R Johnson Cancer cell 35 (4), 545-557, 2019 | 60 | 2019 |
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis J Carlevaro-Fita, A Lanzós, L Feuerbach, C Hong, D Mas-Ponte, ... Communications Biology 3 (1), 1-16, 2020 | 24* | 2020 |
EACR Cancer Genomics 2019 conference: from tumour evolution to personalised immunotherapy A Lanzós, K Elliott The FEBS journal, 2019 | 1 | 2019 |
Integrating deep proteomics profiling with survival analysis to identify novel biomarkers of response to PD-1 blockade in NSCLC patients K Sklodowski, V Dozio, S Lopez-Lastra, A Lanzós, K Beeler, E Romano Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
Cancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs A Vancura, A Lanzós, N Bosch, M Torres, AH Gutierrez, S Haefliger, ... bioRxiv, 2020 | | 2020 |